Office-Based Asthma Screening Intervention

This study has been completed.

Sponsor:

Collaborators:

Halcyon Hill Foundation

Robert Wood Johnson Foundation

Information provided by:

University of Rochester

ClinicalTrials.gov Identifier:

NCT00156468

First received: September 8, 2005

Last updated: May 11, 2011

Last verified: May 2011

History of Changes

Tracking Information

First Received Date ^ICMJE

September 8, 2005

Last Updated Date

May 11, 2011

Start Date ^ICMJE

October 2003

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

"Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00156468 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.

Original Secondary Outcome Measures ^ICMJE

Same as current

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Office-Based Asthma Screening Intervention

Official Title ^ICMJE

Office-Based Asthma Screening Intervention

Brief Summary

In prior work, we found that even children who have been seen by their physicians within the prior six months were frequently misclassified as having mild rather than persistent asthma. This study evaluations whether systematic office-based screening assists primary care physicians in identifying children with significant asthma and improves preventive care for asthma. We hypothesize that standardized screening in the office setting will improve the physician's ability to (a) identify children with significant asthma and (b) prescribe appropriate preventive medications.

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Not Provided

Study Design ^ICMJE

Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Prevention

Condition ^ICMJE

Asthma

Intervention ^ICMJE

Behavioral: Provider Prompt

Study Arm (s)

Not Provided

Publications *

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

365

Completion Date

September 2005

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Children ages 2-12
Children arriving for an office visit in two Rochester, NY pediatric clinics
Children with a prior diagnosis of asthma AND an exacerbation of symptoms within the previous 2 years

Exclusion Criteria:

Children arriving at the office visit with an adult that is not their parent or guardian
Children arriving at the office visit with a parent or guardian that does not speak English
Children with other medical conditions making the assessment of asthma severity difficult (cystic fibrosis, heart conditions, etc.)

Gender

Both

Ages

2 Years to 12 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT Number ^ICMJE

NCT00156468

Other Study ID Numbers ^ICMJE

10035

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

University of Rochester

Collaborators ^ICMJE

Halcyon Hill Foundation
Robert Wood Johnson Foundation

Investigators ^ICMJE

Principal Investigator:

Jill S Halterman, MD, MPH

University of Rochester

Information Provided By

University of Rochester

Verification Date

May 2011

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top